尹达,周旭晨

• 1:大连医科大学附属第一医院心内科

摘要(Abstract)：

<正>严重冠状动脉钙化病变约占经皮冠状动脉介入治疗(PCI)的6%~20%~([1-2])。冠状动脉钙化不仅是主要不良心血管事件(major adverse cardiac events,MACE)发生的高危因素,也常导致支架置入后发生膨胀不良、贴壁不良等其他并发症。冠状动脉钙化程度随着年龄的增长显著增加~([3]),随着中国老龄化社会的到来,冠状动脉钙化病变在PCI治疗中的比例将不断增加,故而开发新的高效安全的治疗手段

关键词(KeyWords)： 冠状动脉钙化病变;旋磨;环形轨道旋磨系统

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 尹达,周旭晨

参考文献(References)：

• [1]Généreux P,Madhavan MV,Mintz GS,et al.Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes.Pooled analysis from the HORIZONSAMI(Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction)and ACUITY(Acute Catheterization and Urgent Intervention Triage Strategy)TRIALS.J Am Coll Cardiol,2014,63(18):1845-1854.
• [2]Bourantas CV,Zhang YJ,Garg S,et al.Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention:a patient-level pooled analysis of 7 contemporary stent trials.Heart,2014,100(15):1158-1164.
• [3]Allison MA,Criqui MH,Wright CM.Patterns and risk factors for systemic calcified atherosclerosis.Arterioscler Thromb Vasc Biol,2004,24(2):331–336.
• [4]Staniloae CS,Korabathina R.Orbital atherectomy:device evolution and clinical data.J Invasive Cardiol,2014,26(5):215–219.
• [5]Heuser RR.Treatment of lower extremity vascular disease:the Diamondback 360 degrees Orbital Atherectomy System.Expert Rev Med Devices,2008,5(3):279–286.
• [6]Parikh K,Chandra P,Choksi N,et al.Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions:the ORBIT I trial.Catheter Cardiovasc Interv,2013,81(7):1134-1139
• [7]Chambers JW,Feldman RL,Himmelstein SI,et al.Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo,severely calcified coronary lesions(ORBIT II).JACC Cardiovasc Interv,2014,7(5):510–518.
• [8]Das T,Mustapha J,Indes J,et al.Technique optimization of orbital atherectomy in calcified peripheral lesions of the lower extremities:the CONFIRM series,a prospective multicenter registry.Catheter Cardiovasc Interv,2014,83(1):115–122.
• [9]Mehta SK,Laster SB.Hemolysis induced pancreatitis after orbital atherectomy in a heavily calcified superficial femoral artery.Catheter Cardiovasc Interv,2008,72(7):1009–1011.
• [10]Staniloae CS,Korabathina R,Lane TA,et al.Study to determine the clinical significance of Hemolysis During Orbital Athe Rectomy(CLEAR study).J Endovasc Ther,2011,18(1):57–63.
• [11]Lee M,Généreux P,Shlofmitz R,et al.Orbital atherectomy for treating de novo,severely calcified coronary lesions:3-year results of the pivotal ORBIT II trial.Cardiovasc Revasc Med,2017,18(4):261-264.
• [12]Chambers JW,Feldman RL,Himmelstein SI,et al.Pivotal trial to evaluate the safety and efficacy of the orbital atherectomy system in treating de novo,severely calcified coronary lesions(ORBIT II).JACC Cardiovasc Interv,2014,7(5):510-518.